Compare GRFS & FNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GRFS | FNB |
|---|---|---|
| Founded | 1940 | 1864 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 6.0B |
| IPO Year | 2006 | N/A |
| Metric | GRFS | FNB |
|---|---|---|
| Price | $8.92 | $16.92 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $10.30 | ★ $18.31 |
| AVG Volume (30 Days) | 667.0K | ★ 5.0M |
| Earning Date | 01-01-0001 | 01-21-2026 |
| Dividend Yield | 1.60% | ★ 2.84% |
| EPS Growth | N/A | ★ 28.48 |
| EPS | 0.64 | ★ 1.40 |
| Revenue | ★ $8,821,017,248.00 | $1,587,400,000.00 |
| Revenue This Year | $5.46 | $17.82 |
| Revenue Next Year | $5.60 | $8.12 |
| P/E Ratio | $17.34 | ★ $12.09 |
| Revenue Growth | ★ 7.31 | 6.34 |
| 52 Week Low | $6.19 | $10.88 |
| 52 Week High | $11.14 | $17.05 |
| Indicator | GRFS | FNB |
|---|---|---|
| Relative Strength Index (RSI) | 52.15 | 66.14 |
| Support Level | $7.64 | $16.34 |
| Resistance Level | $8.90 | $16.85 |
| Average True Range (ATR) | 0.27 | 0.39 |
| MACD | 0.07 | 0.10 |
| Stochastic Oscillator | 92.00 | 93.21 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
F N B Corp provides a full range of financial services, principally to consumers, corporations, governments and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.